The approaching Summer heat appears to send the Antitrust community into a bout of introspection and planning for the future, facing possibly major developments over the months ahead. Efforts to coordinate with scholars and authorities in the increasingly interconnected world of e-commerce and other high-tech issues feature prominently, as well as questions of how to ensure compliance in this rapidly changing and multi-jurisdictional global community.
The Antitrust Division recently issued its 2017 annual spring update. The update emphasizes the Division’s recent litigation victories, particularly in the merger context. In his introductory remarks, Assistant Attorney General Brett Snyder noted the Division’s litigation docket is more active
J. Taylor Kirklin and Melissa R. Ginsberg (Antitrust Update)
Alden Abbott (Truth on the Market)
European competition authorities announced this week an investigation into Aspen Pharmacare’s recent price hikes of five cancer drugs. The European Commission said in a press release that it had “information indicating that Aspen has imposed very significant and unjustified price increases of up to several hundred percent.”
Kathrina Szymborski and William F. Cavanaugh (Antitrust Update)
Dylan Ballard and Amar Naik (Antitrust Law Blog)
Roman Madej (EU Competition Blog/Bryan Cave)
The European Commission increasingly issues large document requests in complex merger cases. The number of requested documents has increased significantly in recent years, from a few hundred to several hundred thousand, in particular in Phase I or Phase II cases that raise substantial issues.
Companies that conspire with their competitors to fix prices, share markets, allocate customers, production or output limitation; have historically faced severe fines from antitrust enforcement all over the world.
Luis Blanquez (The Antitrust Attorney)
Restrictions on internet distribution and competition law compliance generally do not mix. However, in a recent speech, Johannes Laitenberger, a high-ranking official within the Competition Directorate of the European Commission, stated that “while blanket internet sales bans are undoubtedly a hardcore restriction […] this does not apply to all restraints on online sales.”
The car spare-parts market in India is a closed one, because car manufacturers mandate that the authorized dealers source their spare parts only from the Original Equipment Manufacturers (OEMs) or the approved vendors.
Ayushi Singhal (Kluwer Competition)
In a split decision, on April 28, 2017, the Court of Appeals for the District of Columbia Circuit affirmed the district court’s decision to issue a permanent injunction blocking the merger of Anthem, Inc. and Cigna Corp., two of the nation’s largest health insurance providers.
Jamison Davies and Melissa R. Ginsberg (Antitrust Update)
Over the past two decades, rapid technological innovation has transformed the industrial organization of the ag-biotech industry. One of the most striking characteristics of this organizational shift has been a steady increase in consolidation.
Geoffrey Manne (Truth on the Market)
Featured News
Johns Hopkins and Caltech Settle for $35.3M in College Price-Fixing Lawsuit
Jan 22, 2025 by
CPI
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan